Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer
Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer
复制标题
DOI:
10.1016/j.surg.2012.10.007
复制
发表时间:
2013-04-01
期刊:
影响因子:
3.8
通讯作者:
Birner, Peter
中科院分区:
文献类型:
--
作者:
Schoppmann, Sebastian F.;Jesch, Bettina;Birner, Peter
Tumor-associated lymphatic networks are the primary routes for tumor cell dissemination and metastasis. Behind the background of possible lymphangiogenesis-associated therapies, the clinical impact of lymphangiogenesis (measured by lymphatic microvessel density [LMVD]) and specific lymphovascular invasion (LVI) in esophageal cancer remains unclear The aim of this study was to evaluate the clinical role of lymphangiogenesis and LVI in a large cohort of esophageal cancer.Methods. For the specific assessment of LMVD and LVI, 393 tissue samples from a prospective tissue databank of esophageal adenocarcinomas, squamous cell carcinomas, and their precursor lesions were included into this study. LMVD and LVI were assessed by immunostaining for podoplanin, a selective marker of lymphatic endothelium. In addition the peritumoral inflammatory stroma reaction (ISR) was assessed.Results. Patients with high LAND had a significant increased risk to develop LVI (P =.00123; coef ficient of regression [CR7 0.27) and lymph node metastasis (P =.00233), independent of the tumor's histology. During a follow-up of 52 months, patients with high LMVD had a significantly reduced overall survival (OS; P